Literature DB >> 30615801

The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017.

Gemma Tatangelo1, Jennifer Watts2, Karen Lim3, Catherine Connaughton3, Julie Abimanyi-Ochom2, Fredrik Borgström4, Geoff C Nicholson5,6, Catherine Shore-Lorenti5,7, Amanda L Stuart8, Sandra Iuliano-Burns9, Ego Seeman3,9, Richard Prince10, Lyn March11, Marita Cross11, Tania Winzenberg12, Laura L Laslett12, Gustavo Duque5,13, Peter R Ebeling5,7, Kerrie M Sanders5.   

Abstract

Osteoporosis and osteopenia are increasingly prevalent conditions among older adults. Not only do the fractures associated with poor bone health have significant health consequences for the individual, but also their economic impact is placing increasing financial burden on governments and society. This study aimed to determine the direct economic cost of osteoporosis, osteopenia, and fractures among Australians aged 50 years and older in 2017. This study uses previous Australian data on the incidence and prevalence of osteoporosis and osteopenia together with recent Australian data on health service utilization after fracture to provide an estimate of the economic burden of osteoporosis. A bottom-up costing approach was used to determine the average direct health care and non-health care total costs of a fracture, as well as the average community health service costs of managing individuals with osteoporosis or osteopenia. The total direct cost of osteoporosis in Australia in 2017 was estimated to be $3.44 billion (AUD 2017, USD 2.77 billion). Treatment of fractures accounted for 68% of total direct costs, and non-fracture management of osteoporosis accounted for 32%. Hip fractures accounted for the highest proportion (43%) of the total direct cost of fractures, although fractures at "other" sites accounted for 38.5%. Fractures among individuals aged 70 years and older accounted for 74% of the direct costs (55% and 19% in women and men, respectively). Fracture costs in those with osteopenia accounted for 50% of direct fracture treatment costs. This up-to-date cost analysis estimated that costs in 2017 were three times higher than in 2007. These estimates will aid clinicians, policy makers, researchers, and health care organizations to acknowledge the economic importance of reducing osteoporosis-related fractures and associated costs. This provides a strong public health case to promote bone health that will assist in reducing future fracture-related costs.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  FRACTURE; HEALTH ECONOMICS; OSTEOPENIA; OSTEOPOROSIS

Year:  2019        PMID: 30615801     DOI: 10.1002/jbmr.3640

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  26 in total

Review 1.  Gut microbiota: a perspective of precision medicine in endocrine disorders.

Authors:  Salman Shirvani Rad; Amirabbas Nikkhah; Mohammadmahdi Orvatinia; Hanieh-Sadat Ejtahed; Negar Sarhangi; Seyed Hamid Jamaldini; Nazli Khodayari; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  J Diabetes Metab Disord       Date:  2020-08-12

2.  Excess healthcare spending associated with fractures among adults with cerebral palsy.

Authors:  Daniel G Whitney; Michelle S Caird; Karl J Jepsen; Edward A Hurvitz; Richard A Hirth
Journal:  Disabil Health J       Date:  2022-03-10       Impact factor: 4.615

Review 3.  A broader strategy for osteoporosis interventions.

Authors:  Ian R Reid
Journal:  Nat Rev Endocrinol       Date:  2020-03-17       Impact factor: 43.330

4.  Dietary Behaviors That Place Young Adults at Risk for Future Osteoporosis.

Authors:  Alyse Davies; Anna Rangan; Margaret Allman-Farinelli
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

Review 5.  Crosstalk of Brain and Bone-Clinical Observations and Their Molecular Bases.

Authors:  Ellen Otto; Paul-Richard Knapstein; Denise Jahn; Jessika Appelt; Karl-Heinz Frosch; Serafeim Tsitsilonis; Johannes Keller
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

6.  Racial differences in skeletal fragility but not osteoarthritis among women and men with cerebral palsy.

Authors:  Daniel G Whitney
Journal:  Bone Rep       Date:  2019-07-30

Review 7.  Gut microbiota: an overlooked factor that plays a significant role in osteoporosis.

Authors:  Meng-Lei Hao; Guang-Yao Wang; Xiao-Qin Zuo; Chan-Juan Qu; Bo-Chen Yao; Dong-Lai Wang
Journal:  J Int Med Res       Date:  2019-08-22       Impact factor: 1.671

8.  Osteoporosis Epidemiology Among Adults With Cerebral Palsy: Findings From Private and Public Administrative Claims Data.

Authors:  Zachary P French; Michelle S Caird; Daniel G Whitney
Journal:  JBMR Plus       Date:  2019-10-07

9.  Estimating the Fiscal Costs of Osteoporosis in Korea Applying a Public Economic Perspective.

Authors:  Mark P Connolly; Saswat Panda; Ha Young Kim
Journal:  J Bone Metab       Date:  2019-11-30

Review 10.  Dual Effects of Lipid Metabolism on Osteoblast Function.

Authors:  Nathalie S Alekos; Megan C Moorer; Ryan C Riddle
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.